English | Español
Patient Daily | Feb 26, 2026

New study identifies multiple paths for therapy resistance in triple-negative breast cancer
Patient Daily | Feb 26, 2026

FDA shifts stance on drug approvals with move toward single pivotal trial
Patient Daily | Feb 26, 2026

Atara stock rises after report questions FDA’s rejection of cell therapy
Patient Daily | Feb 26, 2026

PRI President Pipes on 340B drug pricing: ‘Patients ultimately pay the price’
Patient Daily | Feb 25, 2026

Legal reporter: GOP has figured out ‘big money is getting in bed with mass tort lawyers’
Patient Daily | Feb 25, 2026

LB Pharma navigates tough markets for successful IPO after promising schizophrenia drug data
Patient Daily | Feb 25, 2026

FARE receives $2.5 million from National Peanut Board for food allergy research
Patient Daily | Feb 25, 2026

BlackDoctor.org calls for reforms to federal 340B drug pricing program

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
Patient Daily | Apr 8, 2026

Breathe Free Teams Pack Meals at Community Volunteer Event, Expanding Care Beyond Clinics